HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chigusa Morizane Selected Research

Self Expandable Metallic Stents

12/2022A novel endoscopic technique using fully covered self-expandable metallic stents for benign strictures after hepaticojejunostomy: the saddle-cross technique (with video).
4/2022Endoscopic ultrasound-guided choledochoduodenostomy without fistula dilation using a stent with a 5.9-Fr delivery system: Comparison to a conventional procedure with fistula dilation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chigusa Morizane Research Topics

Disease

49Neoplasms (Cancer)
12/2022 - 09/2004
35Pancreatic Neoplasms (Pancreatic Cancer)
08/2022 - 01/2005
26Hepatocellular Carcinoma (Hepatoma)
09/2022 - 02/2005
25Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2022 - 01/2003
8Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 10/2013
8Neutropenia
01/2021 - 02/2005
8Adenocarcinoma
10/2020 - 01/2005
8Neoplasm Metastasis (Metastasis)
05/2019 - 12/2007
6Neuroendocrine Carcinoma
01/2020 - 04/2010
6Thrombocytopenia (Thrombopenia)
06/2017 - 02/2005
5Carcinoma (Carcinomatosis)
10/2020 - 08/2005
5Leukopenia
06/2017 - 02/2005
4Cholangiocarcinoma
11/2021 - 07/2008
4Disease Progression
07/2020 - 04/2014
3Pathologic Constriction (Stenosis)
12/2022 - 01/2008
3Stomach Neoplasms (Stomach Cancer)
07/2022 - 11/2020
3Exanthema (Rash)
01/2019 - 10/2012
3Anorexia
01/2019 - 06/2006
2Fever (Fevers)
09/2022 - 04/2014
2Nausea
01/2022 - 06/2006
2Acinar Cell Carcinoma
01/2021 - 11/2009
2Epithelioid Hemangioendothelioma
01/2021 - 10/2018
2Ascites
01/2021 - 12/2007
2Hepatitis
01/2019 - 09/2012
2Stomatitis
01/2019 - 10/2012
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2015 - 04/2010
2Drug-Related Side Effects and Adverse Reactions
10/2014 - 10/2012
2Interstitial Lung Diseases (Interstitial Lung Disease)
12/2012 - 08/2010
2Pneumonia (Pneumonitis)
10/2012 - 01/2009
1Encephalitis (Encephalitis, Rasmussen)
09/2022
1Hyperphosphatemia
07/2022
1Fistula
04/2022

Drug/Important Bio-Agent (IBA)

39GemcitabineFDA Link
01/2022 - 01/2005
24Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2003
9PlatinumIBA
01/2021 - 08/2015
8Sorafenib (BAY 43-9006)FDA Link
10/2020 - 03/2010
8Fluorouracil (Carac)FDA LinkGeneric
06/2017 - 01/2003
6Pharmaceutical PreparationsIBA
06/2022 - 06/2006
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2017 - 02/2005
5Biomarkers (Surrogate Marker)IBA
12/2020 - 10/2013
5Alanine Transaminase (SGPT)IBA
06/2017 - 02/2005
4folfirinoxIBA
08/2022 - 02/2015
4Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2012
4Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2008
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 09/2012
4C-Reactive ProteinIBA
01/2016 - 01/2009
4TegafurIBA
03/2011 - 08/2005
4Epirubicin (Ellence)FDA LinkGeneric
07/2008 - 01/2003
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 07/2015
3Protein Subunit VaccinesIBA
01/2021 - 12/2010
3Peptides (Polypeptides)IBA
01/2021 - 12/2009
3Mitoxantrone (Novantrone)FDA LinkGeneric
06/2017 - 02/2005
3orantinib (SU6668)IBA
10/2014 - 02/2011
3UracilIBA
03/2011 - 08/2005
2SteroidsIBA
09/2022 - 10/2020
2Bevacizumab (Avastin)FDA Link
09/2022 - 08/2018
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
07/2022 - 02/2011
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2021 - 01/2021
2EverolimusFDA Link
11/2021 - 10/2012
2Histone Deacetylase InhibitorsIBA
01/2021 - 01/2019
2resminostatIBA
01/2021 - 01/2019
2VaccinesIBA
01/2021 - 01/2011
2GlypicansIBA
01/2021 - 04/2014
2Circulating Tumor DNAIBA
12/2020 - 12/2015
2regorafenibIBA
10/2020 - 02/2018
2Cytotoxins (Cytolysins)IBA
07/2020 - 08/2015
2Sunitinib (Sutent)FDA Link
06/2019 - 10/2013
2AmylasesFDA Link
01/2019 - 03/2014
2Indicators and Reagents (Reagents)IBA
10/2018 - 01/2016
2Carcinoembryonic AntigenIBA
08/2018 - 09/2004
2trametinibIBA
08/2018 - 01/2018
2N-formylmethionylphenylalanine (FMP)IBA
06/2017 - 02/2005
2Biological ProductsIBA
08/2015 - 03/2014
2Etoposide (VP 16)FDA LinkGeneric
08/2015 - 04/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2014 - 02/2011
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2014 - 02/2011
2Angiogenesis InhibitorsIBA
10/2014 - 02/2011
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2012 - 10/2006
2Tyrosine Kinase InhibitorsIBA
09/2012 - 02/2011
2S 1 (combination)IBA
04/2012 - 12/2010
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2011 - 12/2010
2Transaminases (Aminotransferases)IBA
01/2007 - 01/2005
1PlasticsIBA
12/2022
1Diazepam (Valium)FDA LinkGeneric
09/2022
1atezolizumabIBA
09/2022
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
07/2022
1futibatinibIBA
07/2022
1trastuzumab deruxtecanIBA
06/2022
1DiamondIBA
05/2022

Therapy/Procedure

57Drug Therapy (Chemotherapy)
02/2022 - 01/2005
34Therapeutics
09/2022 - 01/2005
9Combination Drug Therapy (Combination Chemotherapy)
02/2022 - 01/2005
4Stents
12/2022 - 09/2020
2Self Expandable Metallic Stents
12/2022 - 04/2022
2Radiotherapy
09/2017 - 01/2005
2Oral Administration
02/2016 - 04/2014
2Chemoradiotherapy
12/2012 - 01/2005
2Intravenous Infusions
08/2010 - 02/2005
2Palliative Care (Palliative Therapy)
04/2008 - 01/2006
1Choledochostomy
04/2022